Insider Transactions in Q1 2024 at Acadia Pharmaceuticals Inc (ACAD)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 27
2024
|
Brendan Teehan EVP, COO, HEAD OF COMMERCIAL |
SELL
Open market or private sale
|
Direct |
5,140
-12.39%
|
$87,380
$17.9 P/Share
|
|
Mar 27
2024
|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,434
-17.19%
|
$92,378
$17.9 P/Share
|
|
Mar 27
2024
|
Stephen Davis CEO |
SELL
Open market or private sale
|
Direct |
17,714
-12.97%
|
$301,138
$17.9 P/Share
|
|
Mar 25
2024
|
Brendan Teehan EVP, COO, HEAD OF COMMERCIAL |
BUY
Grant, award, or other acquisition
|
Direct |
10,048
+19.5%
|
-
|
|
Mar 25
2024
|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
10,550
+25.02%
|
-
|
|
Mar 25
2024
|
Stephen Davis CEO |
BUY
Grant, award, or other acquisition
|
Direct |
34,666
+20.25%
|
-
|
|
Feb 26
2024
|
Brendan Teehan EVP, COO, HEAD OF COMMERCIAL |
SELL
Open market or private sale
|
Direct |
624
-1.95%
|
$14,976
$24.67 P/Share
|
|
Feb 26
2024
|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
772
-3.54%
|
$18,528
$24.67 P/Share
|
|
Feb 26
2024
|
James Kihara PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
474
-3.99%
|
$11,376
$24.67 P/Share
|
|
Feb 26
2024
|
Stephen Davis CEO |
SELL
Open market or private sale
|
Direct |
5,577
-5.19%
|
$133,848
$24.67 P/Share
|
|
Feb 23
2024
|
Brendan Teehan EVP, COO, HEAD OF COMMERCIAL |
BUY
Exercise of conversion of derivative security
|
Direct |
1,107
+3.34%
|
-
|
|
Feb 23
2024
|
Mark C. Schneyer EVP, CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,353
+5.83%
|
-
|
|
Feb 23
2024
|
James Kihara PRINCIPAL ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
840
+6.61%
|
-
|
|
Feb 23
2024
|
Stephen Davis CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,946
+9.24%
|
-
|
|
Jan 08
2024
|
Austin D. Kim EVP,General Counsel, Secretary |
SELL
Open market or private sale
|
Direct |
590
-1.24%
|
$17,110
$29.96 P/Share
|
|
Jan 08
2024
|
Brendan Teehan EVP, COO, HEAD OF COMMERCIAL |
SELL
Open market or private sale
|
Direct |
731
-2.31%
|
$21,199
$29.96 P/Share
|
|
Jan 08
2024
|
Stephen Davis CEO |
SELL
Open market or private sale
|
Direct |
3,732
-3.72%
|
$108,228
$29.96 P/Share
|
|
Jan 06
2024
|
Austin D. Kim EVP,General Counsel, Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
1,634
+3.33%
|
-
|
|
Jan 06
2024
|
Brendan Teehan EVP, COO, HEAD OF COMMERCIAL |
BUY
Exercise of conversion of derivative security
|
Direct |
1,287
+3.9%
|
-
|
|
Jan 06
2024
|
Stephen Davis CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
9,528
+8.68%
|
-
|